Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doubletsDAE HO LEE; KIM, Sang-We; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 35-39, issn 0344-5704, 5 p.Article

Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancerAHN, Jin-Hee; KANG, Yoon-Koo; KIM, Tae-Won et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 2, pp 104-110, issn 0344-5704Article

Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamideLEE, Je-Hwan; LEE, Kyoo-Hyung; LEE, Jung-Shin et al.British journal of haematology. 2002, Vol 118, Num 4, pp 1087-1094, issn 0007-1048Article

Leptomeningeal carcinomatosis in gastric cancerLEE, Jae-Lyun; KANG, Yoon-Koo; KIM, Sang-We et al.Journal of neuro-oncology. 2004, Vol 66, Num 1-2, pp 167-174, issn 0167-594X, 8 p.Article

Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantationLEE, Je-Hwan; LEE, Jung-Hee; LEE, Kyoo-Hyung et al.British journal of haematology. 2003, Vol 120, Num 4, pp 702-710, issn 0007-1048, 9 p.Article

Spontaneous remission of aplastic anemia : a retrospective analysisLEE, Je-Hwan; LEE, Jung-Hee; SHIN, Young-Rok et al.Haematologica (Roma). 2001, Vol 86, Num 9, pp 928-933, issn 0390-6078Article

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZHENFENG ZHANG; JAE CHEOL LEE; YUN JUNG CHOI et al.Nature genetics. 2012, Vol 44, Num 8, pp 852-860, issn 1061-4036, 9 p.Article

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the LungHAN, Ji-Youn; PARK, Keunchil; LEE, Jung-Shin et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1122-1128, issn 0732-183X, 7 p.Article

Graft-versus-host disease (GVHD)-specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantationLEE, Jung-Hee; LEE, Je-Hwan; CHOI, Seong-Jun et al.British journal of haematology. 2003, Vol 122, Num 4, pp 637-644, issn 0007-1048, 8 p.Article

Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantationLEE, Kyoo-Hyung; LEE, Je-Hwan; LEE, Jung-Hee et al.Haematologica (Roma). 2001, Vol 86, Num 9, pp 999-1001, issn 0390-6078Article

RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT THERAPY IN STAGE II AND III RECTAL CANCER TO DEFINE THE OPTIMAL SEQUENCE OF CHEMOTHERAPY AND RADIOTHERAPY: 10-YEAR FOLLOW-UPKIM, Tae-Won; LEE, Je-Hwan; KIM, Jin-Cheon et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 4, pp 1025-1031, issn 0360-3016, 7 p.Article

Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphomaDOK HYUN YOON; BYEONG SEOK SOHN; PARK, Seo-Jin et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 9, pp 1890-1900, issn 0041-1132, 11 p.Article

Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuriaLEE, Jae-Lyun; LEE, Je-Hwan; LEE, Jung-Shin et al.European journal of haematology. 2003, Vol 71, Num 2, pp 114-118, issn 0902-4441, 5 p.Article

Growth inhibition and chemosensitivity of poorly differentiated human thyroid cancer cell line (NPA) transfected with p53 geneKIM, Sung-Bae; AHN, Ii-Min; PARK, Hyun-Joo et al.Head & neck. 2001, Vol 23, Num 3, pp 223-229, issn 1043-3074Article

A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatmentAHN, Jin-Hee; LEE, Kyoo-Hyung; LEE, Je-Hwan et al.British journal of haematology. 2001, Vol 112, Num 2, pp 527-528, issn 0007-1048Article

Multicenter Phase 2 Study of Belotecan, a New Camptothecin Analog, and Cisplatin for Chemotherapy-Naive Patients With Extensive-Disease Small Cell Lung CancerDAE HO LEE; KIM, Sang-We; SUNG HYUN YANG et al.Cancer. 2010, Vol 116, Num 1, pp 132-136, issn 0008-543X, 5 p.Article

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasisKIM, Jeong-Eun; DAE HO LEE; CHOI, Yunsuk et al.Lung cancer. 2009, Vol 65, Num 3, pp 351-354, issn 0169-5002, 4 p.Article

Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma: A single institutional studyLEE, Jae-Lyun; KIM, Sung-Bae; JUNG, Hwoon-Yong et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 3, pp 207-217, issn 0284-186X, 11 p.Article

Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary reportLEE, Jung-Hee; LEE, Je-Hwan; AHN, Seung-Do et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1751-1758, issn 0732-183XArticle

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantationLEE, Je-Hwan; LEE, Kyoo-Hyung; SHIN KIM et al.Leukemia research. 2001, Vol 25, Num 4, pp 305-312, issn 0145-2126Article

Allogeneic non-myeloablative stem cell transplantation for the patients with heavily pre-treated refractory lymphomaLEE, Je-Hwan; LEE, Jung-Hee; KONG, Yoon-Koo et al.Haematologica (Roma). 2001, Vol 86, Num 10, pp 1114-1115, issn 0390-6078Article

Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II StudyDAE RO CHOI; DAE HO LEE; CHOI, Chang-Min et al.Anticancer research. 2011, Vol 31, Num 10, pp 3457-3462, issn 0250-7005, 6 p.Article

[¹⁸F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung. CommentaryMANKOFF, David A; EARY, Janet F; LEE, Jung-Shin et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, issn 1078-0432, 7159-7160, 7423-7429 [9 p.]Article

Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemiaLEE, Je-Hwan; CHOI, Seong-Jun; LEE, Jung-Shin et al.Haematologica (Roma). 2005, Vol 90, Num 10, pp 1380-1388, issn 0390-6078, 9 p.Article

Prognostic factors identifiable at the time of onset of acute graft-versu-host disease after allogeneic hematopoietic cell transplantationLEE, Kyoo-Hyung; CHOI, Seong-Jun; LEE, Young-Shin et al.Haematologica (Roma). 2005, Vol 90, Num 7, pp 939-948, issn 0390-6078, 10 p.Article